Neocor Therapeutics
PrivateLast Round
Grant
Oct 15, 2025
Total Funding Raised
$940,000
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Neocor Therapeutics is a biotechnology company that is developing a novel gene therapy approach for cardiac diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clinical Trials
Business Model
B2B
Customer Profile
Hardware Sales, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Neocor Therapeutics Comparables
Compare Neocor Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| BiVACOR | 82% | |
| Picard Medical, Inc. | 78% | |
| Carmat | 75% | |
Neocor Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Oct 15, 2025 | ||||
| Grant | Jan 1, 2024 | ||||
| Pre Seed | Dec 1, 2023 |
Neocor Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| SATT Sud-Est | Grant |
| Bpifrance | Grant |
| Crédit Agricole Alpes Provence | Pre Seed |
| Incubateur Impulse | Pre Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Oct 15, 2025
$431K grant received from Bpifrance.
- Jan 1, 2024
$437K grant received from SATT Sud-Est.
Neocor Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Neocor Therapeutics's valuation, stock price, and market status.